clinical dose escalation

Advertisement

cGxPJobs Banner

PRAME Cell Therapy Shows Strong Early Responses in Phase 1 Study

HOUSTON, Texas & TÜBINGEN, Germany — December 11, 2025 — Immatics N.V. announced compelling Phase 1a dose-escalation data for...

By cGxPwire Editor
December 11, 2025

Read More

Advertisement

cGxPJobs

Directory